Offer - Urjas Oil for just ₹ 1 X
Rebose 25 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Diabetes Type 2 are some of its major therapeutic uses.
The optimal dosage of Rebose 25 Mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Rebose 25 Mg Tablet as well, which are listed below. Usually, these side effects of Rebose 25 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Rebose 25 Mg Tablet has a Safe effect for pregnant women and Unknown effect on lactating mothers. In addition, Rebose 25 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Rebose 25 Mg Tablet related warnings section.
Rebose 25 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Rebose 25 Mg Tablet in conditions like Kidney Disease, Liver Cirrhosis, Inflammatory Bowel Disease. Other contraindications of Rebose 25 Mg Tablet have been discussed in the sections ahead.
Drug interactions for Rebose 25 Mg Tablet have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that Rebose 25 Mg Tablet is safe while driving, and is is addictive in nature.
Rebose 25 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Rebose 25 Mg Tablet safe for pregnant women?
Rebose is safe for pregnant women.
Is the use of Rebose 25 Mg Tablet safe during breastfeeding?
Information about safety of Rebose for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Rebose 25 Mg Tablet on the Kidneys?
Effects of Rebose on kidney can be severe. It is not safe to use it without doctor's advice.
What is the effect of Rebose 25 Mg Tablet on the Liver?
Effects of Rebose on the liver can be severe. It is not safe for use without doctor's advice.
What is the effect of Rebose 25 Mg Tablet on the Heart?
Side effects of Rebose rarely affect the heart.
Rebose 25 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Rebose 25 Mg Tablet unless your doctor advises you to do so -
Is this Rebose 25 Mg Tablet habit forming or addictive?
Rebose 25 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Rebose 25 Mg Tablet since it does not cause drowsiness.
Is it safe?
Yes, Rebose 25 Mg Tablet is safe for use.
Is it able to treat mental disorders?
No, the use of Rebose 25 Mg Tablet in mental disorders is not effective.
Interaction between Food and Rebose 25 Mg Tablet
Information is not available on the interaction of any foods with Rebose 25 Mg Tablet, due to a lack of research on this.
Interaction between Alcohol and Rebose 25 Mg Tablet
Taking Rebose 25 Mg Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Precose® (acarbose tablets)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277